Cellectar Biosciences Inc. (NASDAQ: CLRB) started the day on July 14, 2021, with a price decrease of -1.80% at $1.09. During the day, the stock rose to $1.15 and sunk to $1.07 before settling in for the price of $1.11 at the close. Taking a more long-term approach, CLRB posted a 52-week range of $1.01-$2.98. Meanwhile, its Annual Earning per share during the time was 59.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 58.50%. This publicly-traded company’s shares outstanding now amounts to $48.14 million, simultaneously with a float of $47.70 million. The organization now has a market capitalization sitting at $54.50 million. At the time of writing, stock’s 50-day Moving Average stood at $1.3604, while the 200-day Moving Average is $1.6198.
Cellectar Biosciences Inc. (CLRB) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Cellectar Biosciences Inc.’s current insider ownership accounts for 0.20%, in contrast to 38.80% institutional ownership. According to the most recent insider trade that took place on Mar 04, this organization’s President and CEO bought 5,100 shares at the rate of 1.70, making the entire transaction reach 8,659 in total value, affecting insider ownership by 86,401. Preceding that transaction, on Dec 28, Company’s Chief Business Officer bought 29,630 for 1.35, making the whole transaction’s value amount to 40,000. This particular insider is now the holder of 102,148 in total.
Cellectar Biosciences Inc. (CLRB) Earnings and Revenue Records
This company achieved a return on equity of -47.28.
Cellectar Biosciences Inc.’s EPS increase for this current 12-month fiscal period is 58.50% and is forecasted to reach -0.47 in the upcoming year.
Cellectar Biosciences Inc. (NASDAQ: CLRB) Trading Performance Indicators
Let’s observe the current performance indicators for Cellectar Biosciences Inc. (CLRB). It’s Quick Ratio in the last reported quarter now stands at 10.80. The Stock has managed to achieve an average true range (ATR) of 0.08.
In the same vein, CLRB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.66, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be -0.47 at the market close of one year from today.
Technical Analysis of Cellectar Biosciences Inc. (CLRB)
If we take a close look at the recent performances of Cellectar Biosciences Inc. (NASDAQ: CLRB), its last 5-days Average volume was 1.83 million that shows progress from its year to date volume of 1.29 million. During the previous 9 days, stock’s Stochastic %D was recorded 16.85% While, its Average True Range was 0.0806.
Raw Stochastic average of Cellectar Biosciences Inc. (CLRB) in the period of the previous 100 days is set at 1.42%, which indicates a major fall in contrast to 8.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 56.55% that was lower than 70.86% volatility it exhibited in the past 100-days period.